Off-Label Use OK When Not Promoted, GSK Exec Says
“Off-label uses, especially in the depression area, aren’t uncommon,” James Millar, GSK vice president of strategic pricing, contracting and marketing, told a jury in the trial of the drugmaker's ex-associate general counsel, Lauren Stevens.
“That’s where clinical judgment comes into play. While you may use Wellbutrin...
To view the full article, register now.